These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 15991801

  • 21. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L.
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [Abstract] [Full Text] [Related]

  • 22. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 23. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 24. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Nov; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 25. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J, Jeyasekharan AD, Theunissen R, Tervaert JW.
    Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
    [Abstract] [Full Text] [Related]

  • 26. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 27. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 28. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW, Silva NP, de Carvalho JF, D'Almeida V, Noguti MA, Sato EI.
    Lupus; 2007 Nov; 16(10):782-7. PubMed ID: 17895300
    [Abstract] [Full Text] [Related]

  • 29. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [Abstract] [Full Text] [Related]

  • 30. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 31. Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Gushiken FC, Arnett FC, Ahn C, Thiagarajan P.
    Arthritis Rheum; 1999 Jun; 42(6):1189-93. PubMed ID: 10366111
    [Abstract] [Full Text] [Related]

  • 32. [Anti-beta 2 glycoprotein I antibodies. Relationship with antiphospholipid antibodies and thrombosis].
    Ordi Ros J, Falgà Tirado C, Monegal Ferran F, Selva O'Callaghan A, Pérez Pemán P, Cucurull E, Vilardell Tarres M.
    Med Clin (Barc); 1995 Feb 25; 104(7):245-8. PubMed ID: 7731286
    [Abstract] [Full Text] [Related]

  • 33. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y.
    Haematologica; 2006 May 25; 91(5):699-702. PubMed ID: 16627257
    [Abstract] [Full Text] [Related]

  • 34. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
    Saxena R, Saraya AK, Dhot PS, Singh Y, Malaviya AN.
    Natl Med J India; 1994 May 25; 7(4):163-5. PubMed ID: 7950946
    [Abstract] [Full Text] [Related]

  • 35. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
    Bertolaccini ML, Mepani K, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2007 Apr 25; 66(4):533-6. PubMed ID: 17020907
    [Abstract] [Full Text] [Related]

  • 36. [Antiphospholipid syndrome diagnosis: an update].
    Visseaux B, Masliah-Planchon J, Fischer AM, Darnige L.
    Ann Biol Clin (Paris); 2011 Apr 25; 69(4):411-8. PubMed ID: 21896405
    [Abstract] [Full Text] [Related]

  • 37. Cutaneous manifestations associated with antiphospholipid antibodies.
    Diógenes MJ, Diógenes PC, de Morais Carneiro RM, Neto CC, Duarte FB, Holanda RR.
    Int J Dermatol; 2004 Sep 25; 43(9):632-7. PubMed ID: 15357740
    [Abstract] [Full Text] [Related]

  • 38. [Primary antiphospholipid syndrome].
    Popa A, Voinea L, Pop M, Stana D, Dascalu AM, Alexandrescu C, Ciuluvica R.
    Oftalmologia; 2008 Sep 25; 52(1):13-7. PubMed ID: 18714484
    [Abstract] [Full Text] [Related]

  • 39. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD.
    Lupus; 2010 May 25; 19(6):711-6. PubMed ID: 20064910
    [Abstract] [Full Text] [Related]

  • 40. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul 25; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.